Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
Clinical trial NCT02365766 · COMPLETED
Trial details
- NCT number
- NCT02365766
- Sponsor
- Jason R. Brown
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-27
- Primary completion
- 2020-08-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.